In conclusion, omega-3 fatty acids alleviate cancer-associated chronic inflammation and facilitate antitumor therapy by inhibiting NF-κB and reducing COX-2 and pro-inflammatory mediator production. This evidence concerns the gene PTGS2 and cancer.